# DIBBS #SPE2DP-27-T-0154

DLA request for four bottles of moxifloxacin hydrochloride tablets

**Posted:** October 26, 2026
**Respond By:** November 02, 2026
**Identifier:** SPE2DP-27-T-0154
**NAICS:** 424210

DLA Troop Support is seeking four bottles of moxifloxacin hydrochloride tablets for delivery to Fort Campbell, Kentucky.
- Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA; contact: Nicholas Quigley.
- Product: 4 bottles of moxifloxacin hydrochloride 400 mg tablets, 30 tablets per bottle; NSN 6505-01-503-4772.
- **Approved OEM sources:** Teva Pharmaceuticals USA, Inc. (NDC 00093-7387-56) and Rising Pharma Holdings, Inc. (NDC 57237-0156-30). These are alternate sources for the same item.
- Requirements: Store at controlled room temperature and avoid high humidity. Delivery is FOB destination to Fort Campbell, Kentucky, within 20 days after award.
- No additional product specifications are provided.

### Description

MOXIFLOXACIN HYDROCHLO (QTY: 4, NSN: 6505-01-503-4772, Purchase Request: 7018846365)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP27T0154)